Auour Investments LLC Atea Pharmaceuticals, Inc. Call Options Transaction History
Auour Investments LLC
- $283 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AVIR
# of Institutions
109Shares Held
48.8MCall Options Held
0Put Options Held
14.1K-
Black Rock Inc. New York, NY9.12MShares$32 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$26.7 Million20.73% of portfolio
-
Tang Capital Management LLC San Diego, CA4.89MShares$17.2 Million1.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$17.2 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$8.72 Million2.68% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $292M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...